KIORA PHARMACEUTICALS, INC. Operating Lease, Liability, Current
KIORA PHARMACEUTICALS, INC. (KPRX) had Operating Lease, Liability, Current of $172.43 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-07
- 2026-06-30: Operating Lease, Liability, Current $172.43K.
- 2026-03-31: Operating Lease, Liability, Current $178.22K.
- 2025-12-31: Operating Lease, Liability, Current $164.46K.
- 2025-09-30: Operating Lease, Liability, Current $155.93K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $172.43K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $178.22K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $164.46K 10-Q · filed 2026-08-07 |
| 2025-09-30 | $155.93K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $143.33K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $71.55K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $23.36K 10-K · filed 2026-03-25 |
| 2024-09-30 | $33.45K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $42.13K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $47.85K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $47.07K 10-K · filed 2025-03-25 |
| 2023-09-30 | $18.73K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $39.01K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $73.29K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $105.78K 10-K · filed 2024-03-25 |
| 2022-09-30 | $131.48K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $137.67K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $92.32K 10-Q · filed 2022-07-08 |
| 2021-12-31 | $118.85K 10-K · filed 2023-03-23 |
| 2021-09-30 | $144.74K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $170.06K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $82.79K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $48.30K 10-K/A · filed 2022-07-07 |
| 2019-12-31 | $83.93K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |